| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-05-22 15:12:06 UTC |
|---|
| Update Date | 2022-09-22 17:43:49 UTC |
|---|
| HMDB ID | HMDB0002725 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Nandrolone |
|---|
| Description | Nandrolone is a C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone, but it has one less carbon atom at the 19 position (Pubchem). Nandrolone is an anabolic steroid occurring naturally in the human body, albeit in small quantities. Nandrolone is most commonly sold commercially as its decanoate ester (Deca-Durabolin) and less commonly as a phenylpropionate ester (Durabolin). Nandrolone use is indirectly detectable in urine tests by testing for the presence of 19-norandrosterone, a metabolism product of this molecule. The International Olympic Committee has set a limit of 2 ng per ml of urine as the upper limit, beyond which an athlete is suspected of doping (Wikipedia ). |
|---|
| Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (17beta)-17-Hydroxyestr-4-en-3-one | ChEBI | | 17beta-Hydroxy-19-nor-4-androsten-3-one | ChEBI | | 17beta-Hydroxy-4-estren-3-one | ChEBI | | 17beta-Hydroxyestr-4-en-3-one | ChEBI | | 19-Norandrostenolone | ChEBI | | 19-Nortestosterone | ChEBI | | 4-Estren-17beta-ol-3-one | ChEBI | | Decadura | Kegg | | (17b)-17-Hydroxyestr-4-en-3-one | Generator | | (17Β)-17-hydroxyestr-4-en-3-one | Generator | | 17b-Hydroxy-19-nor-4-androsten-3-one | Generator | | 17Β-hydroxy-19-nor-4-androsten-3-one | Generator | | 17b-Hydroxy-4-estren-3-one | Generator | | 17Β-hydroxy-4-estren-3-one | Generator | | 17b-Hydroxyestr-4-en-3-one | Generator | | 17Β-hydroxyestr-4-en-3-one | Generator | | 4-Estren-17b-ol-3-one | Generator | | 4-Estren-17β-ol-3-one | Generator | | (17-beta)-17-Hydroxyestr-4-en-3-one | HMDB | | 17-beta-Hydroestr-4-en-3-one | HMDB | | Deca-durabolin | HMDB | | Durabolin | HMDB | | Menidrabol | HMDB | | Nandrolon | HMDB | | Nandrolona | HMDB | | Nandrolone base | HMDB | | Nandrolone decanoate | HMDB | | Nandrolone decanoic acid | HMDB | | Nandrolone phenpropionate | HMDB | | Nandrolonum | HMDB | | Norandrostenolon | HMDB | | Norandrostenolone | HMDB | | Nortestonate | HMDB | | Nortestosterone | HMDB | | Nortestosteronum | HMDB | | Oestrenolon | HMDB | | 17-Hydroxy-estr-4-ene-3-one | MeSH, HMDB | | Estrenolone | MeSH, HMDB | | 17beta Hydroxy 19 nor 4 androsten 3 one | MeSH, HMDB |
|
|---|
| Chemical Formula | C18H26O2 |
|---|
| Average Molecular Weight | 274.3978 |
|---|
| Monoisotopic Molecular Weight | 274.193280076 |
|---|
| IUPAC Name | (1S,2R,10R,11S,14S,15S)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
|---|
| Traditional Name | (1S,2R,10R,11S,14S,15S)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
|---|
| CAS Registry Number | 434-22-0 |
|---|
| SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |
|---|
| InChI Identifier | InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 |
|---|
| InChI Key | NPAGDVCDWIYMMC-IZPLOLCNSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Estrane steroids |
|---|
| Direct Parent | Estrogens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Estrogen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Cyclic ketone
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 118 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 3.09 mg/mL at 25 °C | Not Available | | LogP | 2.62 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 167.5 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.08 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.0844 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.32 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2466.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 397.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 196.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 188.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 413.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 597.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 619.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 102.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1232.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 435.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1419.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 374.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 412.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 312.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 423.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 47.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Nandrolone,1TMS,isomer #1 | C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2677.8 | Semi standard non polar | 33892256 | | Nandrolone,1TMS,isomer #2 | C[C@]12CC[C@@H]3[C@H]4CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O | 2555.6 | Semi standard non polar | 33892256 | | Nandrolone,2TMS,isomer #1 | C[C@]12CC[C@@H]3[C@H]4CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2621.6 | Semi standard non polar | 33892256 | | Nandrolone,2TMS,isomer #1 | C[C@]12CC[C@@H]3[C@H]4CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2657.8 | Standard non polar | 33892256 | | Nandrolone,2TMS,isomer #1 | C[C@]12CC[C@@H]3[C@H]4CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2953.7 | Standard polar | 33892256 | | Nandrolone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C | 2935.8 | Semi standard non polar | 33892256 | | Nandrolone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 | 2856.6 | Semi standard non polar | 33892256 | | Nandrolone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3182.6 | Semi standard non polar | 33892256 | | Nandrolone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3140.1 | Standard non polar | 33892256 | | Nandrolone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3196.8 | Standard polar | 33892256 |
|
|---|
| General References | - Segura J, Pichini S, Peng SH, de la Torre X: Hair analysis and detectability of single dose administration of androgenic steroid esters. Forensic Sci Int. 2000 Jan 10;107(1-3):347-59. [PubMed:10689586 ]
- Venken K, Boonen S, Van Herck E, Vandenput L, Kumar N, Sitruk-Ware R, Sundaram K, Bouillon R, Vanderschueren D: Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. Bone. 2005 Apr;36(4):663-70. [PubMed:15784189 ]
- Noorafshan A, Karbalay-Doust S, Ardekani FM: High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in rats. APMIS. 2005 Feb;113(2):122-5. [PubMed:15723686 ]
- Tai SS, Xu B, Sniegoski LT, Welch MJ: Development and evaluation of a candidate reference measurement procedure for the determination of 19-norandrosterone in human urine using isotope-dilution liquid chromatography/tandem mass spectrometry. Anal Chem. 2006 May 15;78(10):3393-8. [PubMed:16689542 ]
- Summerfield AE, Diaz Cruz PJ, Dolenga MP, Smith HE, Strader CD, Toney JH: Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein. Mol Pharmacol. 1995 May;47(5):1080-8. [PubMed:7746275 ]
- Schmitt N, Flament MM, Goubault C, Legros P, Grenier-Loustalot MF, Denjean A: Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc. 2002 Sep;34(9):1436-9. [PubMed:12218735 ]
- Hold KM, Borges CR, Wilkins DG, Rollins DE, Joseph RE Jr: Detection of nandrolone, testosterone, and their esters in rat and human hair samples. J Anal Toxicol. 1999 Oct;23(6):416-23. [PubMed:10517545 ]
- Silberzahn P, Gaillard JL, Quincey D, Dintinger T, Al-Timimi I: Aromatization of testosterone and 19-nortestosterone by a single enzyme from equine testicular microsomes. Differences from human placental aromatase. J Steroid Biochem. 1988 Jan;29(1):119-25. [PubMed:3347045 ]
- Foreman MI, Clanachan I, Kelly IP: The diffusion of nandrolone through occluded and non-occluded human skin. J Pharm Pharmacol. 1978 Mar;30(3):152-7. [PubMed:24687 ]
- Foreman MI, Kelly I: The diffusion of nandrolone through hydrated human cadaver skin. Br J Dermatol. 1976 Sep;95(3):265-70. [PubMed:974017 ]
- Baume N, Avois L, Schweizer C, Cardis C, Dvorak J, Cauderay M, Mangin P, Saugy M: [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism. Clin Chem. 2004 Feb;50(2):355-64. Epub 2003 Nov 21. [PubMed:14633920 ]
- Frisoli A Jr, Chaves PH, Pinheiro MM, Szejnfeld VL: The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2005 May;60(5):648-53. [PubMed:15972619 ]
- Farjam A, Vreuls JJ, Cuppen WJ, Brinkman UA, de Jong GJ: Direct introduction of large-volume urine samples into an on-line immunoaffinity sample pretreatment-capillary gas chromatography system. Anal Chem. 1991 Nov 1;63(21):2481-7. [PubMed:1763806 ]
- Kintz P, Cirimele V, Dumestre-Toulet V, Ludes B: Doping control for nandrolone using hair analysis. J Pharm Biomed Anal. 2001 Mar;24(5-6):1125-30. [PubMed:11248508 ]
|
|---|